World's Best Scientists 2026 revealed!
Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

D-Index & Metrics

Medicine

D-Index
119
Citations
63338
World Ranking
3847
National Ranking
211

Hossein Ardeschir Ghofrani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hossein Ardeschir Ghofrani sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 680 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hossein Ardeschir Ghofrani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hossein Ardeschir Ghofrani sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 119 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hossein Ardeschir Ghofrani is affiliated with the University of Giessen in Germany and conducts research primarily in the field of Medicine, with a significant focus on Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. Their work spans several related subfields including Genetics, Molecular Biology, and Hepatology.

The research topics covered by Ghofrani include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular Issues in Pregnancy, Vascular Anomalies and Treatments, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Liver Disease and Transplantation.

Ghofrani has published extensively, with a notable presence in key medical journals. The most frequent publication venues for their research are:

  • The Journal of Heart and Lung Transplantation
  • European Respiratory Journal
  • Pneumologie
  • Pulmonary Circulation
  • Circulation

Noteworthy recent papers authored or co-authored by Ghofrani include:

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Respiratory Journal
  • Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension, 2023, New England Journal of Medicine
  • ERS statement on chronic thromboembolic pulmonary hypertension, 2020, European Respiratory Journal
  • COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension, 2021, European Respiratory Journal

The scientist often collaborates with several frequent co-authors, including:

  • Werner Seeger
  • Henning Gall
  • Marius M. Hoeper
  • Khodr Tello
  • Manuel J. Richter

Best Publications

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Inhaled iloprost for severe pulmonary hypertension.

    Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam

  • Macitentan and morbidity and mortality in pulmonary arterial hypertension.

    Tomás Pulido;Igor Adzerikho;Richard N. Channick;Marion Delcroix

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

    Hossein-Ardeschir Ghofrani;Andrea M D'Armini;Friedrich Grimminger;Marius M Hoeper

  • Riociguat for the Treatment of Pulmonary Arterial Hypertension

    Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig

  • Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

    Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres

  • Tadalafil Therapy for Pulmonary Arterial Hypertension

    Nazzareno Galiè;Bruce H. Brundage;Hossein A. Ghofrani;Ronald J. Oudiz

  • Reversal of experimental pulmonary hypertension by PDGF inhibition.

    Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti

  • Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

    Nazzareno Galiè;Joan A. Barberà;Adaani E. Frost;Hossein-Ardeschir Ghofrani

  • Selexipag for the treatment of pulmonary arterial hypertension.

    Olivier Sitbon;Richard Channick;Kelly M Chin;Aline Frey

  • Chronic thromboembolic pulmonary hypertension

    Nick H. Kim;Marion Delcroix;Xavier Jais;Michael M. Madani

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Mechanisms of disease: pulmonary arterial hypertension

    Ralph T. Schermuly;Hossein A. Ghofrani;Martin R. Wilkins;Friedrich Grimminger

  • Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers.

    Marius M. Hoeper;Stephen H. Lee;Robert Voswinckel;Massimiliano Palazzini

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

    Xavier Jaïs;Andrea M. D'Armini;Pavel Jansa;Adam Torbicki

  • Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

    Hossein A. Ghofrani;Ian H. Osterloh;Friedrich Grimminger

  • Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

    Robyn J. Barst;J. Simon R. Gibbs;Hossein A. Ghofrani;Marius M. Hoeper

  • Imatinib for the treatment of pulmonary arterial hypertension.

    Hossein A. Ghofrani;Werner Seeger;Friedrich Grimminger

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study

    Gùrald Simonneau;Andrea D'Armini;Hossein Ghofrani;Friedrich Grimminger

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Friedrich Grimminger
Friedrich Grimminger University of Giessen
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Norbert Weissmann
Norbert Weissmann University of Giessen
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Horst Olschewski
Horst Olschewski Medical University of Graz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical studies in the USA doesn’t just mean traditional medical school. There are numerous online pathways in healthcare that offer flexible learning and a range of rewarding careers.

For those considering nursing, online nursing courses provide accessible ways to start a healthcare career or enhance existing skills. Many students look for budget-friendly options such as the cheapest online bsn programs to upgrade their credentials, leading to increased job prospects and higher salaries.

Advanced nursing degrees can be pursued online as well. Those interested in leadership or specialized clinical roles can explore the cheapest dnp programs online. Not already a nurse but want to move directly into advanced practice? You can fast-track your career through direct entry nurse practitioner programs for non-nurses online.

These online pathways make healthcare careers more accessible, allowing students to balance studies with life’s responsibilities while preparing for high-demand roles in the medical field.

Best Scientists Citing Hossein Ardeschir Ghofrani

Trending Scientists